Johor has established itself as Malaysia’s second-largest residential market in 2025, based on both transaction volume and value, according to JLL.
JOHOR, MALAYSIA – Media OutReach Newswire – 31 July 2026 – From 1 January 2026, foreign purchasers of residential property in Malaysia are subject to a flat 8% stamp duty rate on the transfer, replacing the previous fixed 4% rate. Meanwhile, a separate stamp duty remission continues to apply within the Forest City Special Financial Zone (SFZ), subject to defined eligibility conditions. Forest City has published a property verification guide for prospective foreign buyers, providing a detailed overview of the ownership framework, foreign-purchaser requirements and applicable tax treatment for property acquisitions within Forest City in Johor.
Forest City waterfront residential development in Iskandar Puteri, Johor
Forest City is a master-planned development in Iskandar Puteri, Johor, with many residential units held under freehold tenure. Foreign buyers may purchase residential property in Forest City subject to Malaysia’s foreign-ownership rules. Under the Forest City Special Financial Zone framework, eligible individual purchasers who buy completed residential or commercial units directly from the developer may receive a 50% stamp duty remission on the instrument of transfer and the loan or financing agreement. To qualify, the sale and purchase agreement (SPA) must be executed between 1 September 2024 and 31 December 2034, and construction must have been completed before 1 September 2024.
Foreign Ownership and Title Structure in Forest City
Foreign buyers are permitted to purchase residential units in Forest City, provided the transaction meets Malaysia’s applicable foreign ownership rules, including any state authority approval required for the acquisition.
Foreign buyers should distinguish between Malaysia’s general state-level minimum purchase-price rules and the Forest City SFZ-linked route, as the applicable threshold may depend on the buyer’s intended purchase and residency pathway. Johor’s general minimum threshold for foreign residential acquisition is generally set at RM1 million. The Forest City SFZ MM2H-linked route generally starts at RM500,000 for qualifying purchases from the developer, but buyers should confirm the current threshold, timing and source-of-purchase requirements with a licensed Malaysia My Second Home (MM2H) agent and Malaysian conveyancing lawyer.
The majority of residential units at Forest City are held on freehold tenure, meaning the tenure is not subject to a fixed lease-expiry period. Upon conducting a land title search, the buyer’s lawyer will obtain the title document, which clearly indicates the tenure type, whether freehold or leasehold. Marketing materials, project descriptions and buyer summaries should not be treated as substitutes for title verification.
Forest City SFZ Stamp Duty Remission
Within the Forest City SFZ, eligible individual purchasers buying completed residential or commercial units directly from the developer may claim a 50% remission on stamp duty payable on the instrument of transfer and on the instrument of loan or financing agreement.
The remission is subject to gazetted eligibility conditions, including purchaser type, source of purchase, SPA execution period and construction completion date. Sub-sale and resale transactions do not fall within the stated scope of this individual-purchaser remission. Corporate purchasers should assess any applicable SFZ treatment separately against the relevant remission order and professional tax advice.
In practical terms, the remission may reduce two key transaction costs: stamp duty on the property transfer and stamp duty on the loan or financing agreement. The actual saving will depend on the property price, financing amount, buyer category and applicable stamp duty rate. EY Malaysia and Lexology provide additional details from a third-party perspective.
Forest City SFZ Stamp Duty Remission vs Standard Rules for Foreign Buyers:
Element
Forest City SFZ Stamp Duty Remission
Standard Stamp Duty Rules for Foreign Buyers
(from 1 Jan 2026)
Stamp duty on transfer
50% remission under the gazetted order
Flat 8% on residential property
Stamp duty on loan/financing
50% remission under the gazetted order
0.5% of loan amount, standard
SPA execution period
1 Sep 2024 – 31 Dec 2034
No specified expiry date
Construction completion required
Before 1 Sep 2024
Not applicable
Eligible buyer type
Individual purchasers only
Applicable to all buyers, subject to the relevant rules
Eligible purchase source
Direct purchase from the developer only
Developer purchase or sub-sale transaction
What the Forest City SFZ Adds Beyond Stamp Duty
The Forest City SFZ offers benefits beyond the stamp duty remission described above. For property buyers, the designation provides three key considerations for property buyers: the 50% stamp duty remission for eligible direct purchases, the SFZ-tier MM2H pathway for qualifying buyers purchasing a Forest City property valued at RM500,000 or above, and the broader policy support associated with Forest City’s role within Johor’s cross-border growth strategy.
While the SFZ MM2H requires applicants to purchase property in Forest City, they are not required to live in it. Approved holders can rent out the property and are free to live anywhere in Malaysia, including Kuala Lumpur, Penang, and other cities. In other words, the SFZ MM2H not only offers a convenient pathway to long-term residency but also gives holders considerable flexibility in where they live. Even without long-term residency in Johor, the SFZ MM2H may offer a comparatively accessible pathway to long-term residency, subject to the applicable eligibility requirements, with lower entry requirements and a clearer approval process, balancing affordability, policy stability, and proximity to Singapore.
Under the Johor-Singapore Special Economic Zone (JS-SEZ) framework, policy consultations and commitments are turning into approved projects, investment, and employment opportunities, while cross-border facilitation measures continue to improve, supporting greater cross-border mobility between Johor and Singapore. Forest City itself has built a comprehensive ecosystem of amenities, combining daily convenience, residential safety, and international connectivity. Residents can reach Singapore via the Second Link, and Forest City is only about two kilometres from Singapore across the Johor Strait. The upcoming Johor-Singapore Rapid Transit System (RTS Link) is expected to further improve cross-border connectivity once passenger service begins.
The area is home to residents from over 20 countries, forming a diverse international community. Forest City features international schools and convenient access to a range of healthcare facilities, making it ideal for long-term family residence. Even for those not residing long-term, Forest City’s comprehensive planning, 24-hour property management, and dedicated security system ensure that owners’ assets are well protected. Furthermore, two championship-level golf courses and waterfront facilities offer high-quality leisure options.
These amenities, combined with the MM2H residency status, present a viable solution that balances quality of life and residency planning. More importantly, the financial district is rapidly evolving into a leading financial and digital economy hub, having already attracted 260 investment enquiries and being on track to exceed its RM2 billion investment target this year, as financial institutions and businesses progressively establish a presence there. At the same time, Forest City has secured Malaysian Digital Status and duty‑free island status, contributing to the continued growth of its resident population and consumer market. These policies and infrastructure enhancements significantly reinforce Forest City’s attractiveness and cross‑border connectivity. In particular, the economic activity and population growth supported by SFZ’s tax incentives, industrial clustering, Digital Status, and duty‑free island policies provide robust structural support for the long‑term value of its properties.
Key Considerations Before Entering an SPA in 2026
Title and tenure: Confirm the title type and tenure of the selected unit through a current land title search conducted by a Malaysian conveyancing lawyer.
SFZ stamp duty remission: Review eligibility for the 50% remission, including purchaser type, source of purchase, SPA execution period and unit completion date.
Foreign-buyer threshold: Confirm the applicable minimum purchase, including whether the general Johor threshold or the Forest City SFZ MM2H-linked pathway applies.
Stamp duty treatment: Request a written breakdown of stamp duty on the property transfer and any loan or financing agreement, before and after the SFZ remission.
MM2H linkage, if applicable: Where the purchase is linked to an SFZ MM2H application, confirm the current deposit, age, minimum-stay and property-purchase timing requirements with a licensed MM2H agent.
Is Forest City Worth Buying in 2026? Three Buyer Profiles
Forest City properties may serve different purposes for cross-border homeowners, MM2H applicants and institutional or corporate investors.
Singapore-based foreign buyers: For buyers seeking a freehold cross-border base, the SFZ stamp duty remission is relevant where the unit qualifies. Together with the upcoming RTS Link, Forest City’s cross-border accessibility is expected to improve further.
MM2H-route buyers: For buyers using the Forest City SFZ MM2H pathway, the RM500,000 entry point for qualifying developer purchases is a key consideration. The property purchase requirement is part of the route, and buyers should confirm the applicable 90-day post-approval purchase timeline with a licensed MM2H agent.
Institutional and business-linked investors: The SFZ incentives are primarily designed for financial institutions, family offices, fintech operators and related business activity. For this segment, residential investment considerations should be assessed alongside broader SFZ-related economic activity, including family-office activity, the potential inflow of skilled professionals and JSSEZ-related demand.
What Buyers Should Confirm Separately
This guide does not provide fixed price quotations, guarantee rental yields or project future capital appreciation, as these depend on unit type, launch phase, vacancy assumptions, financing terms and market conditions.
Prospective buyers should confirm current pricing with recent market listings and current prices provided by the developer’s sales gallery. They should also verify foreign-buyer rules, unit-level tenure, and title procedures with a Malaysian conveyancing lawyer. A current title search can help confirm the registered owner, tenure, encumbrances and other legal particulars of the selected unit before the buyer signs an SPA or makes a deposit.
Financing should also be assessed separately with Malaysian banks or a mortgage broker, as foreign-buyer loan-to-value ratios, rates and approval conditions vary by borrower profile and lender. Forest City’s investment overview provides broader context, but transaction-specific pricing, financing, title status and yield assumptions should be verified independently.
Conclusion
While no property guide can replace advice from a Malaysian conveyancing lawyer, tax adviser or licensed property consultant, Forest City’s 2026 proposition is now supported by clearer reference points: unit-level title verification, a gazetted 50% SFZ stamp duty remission, and the RTS Link’s expected five-minute Johor Bahru–Singapore rail crossing once passenger service begins.
With the SFZ remission window running until 31 December 2034, 2026 should therefore be viewed not as a deadline, but as an appropriate time for careful due diligence. Purchasers should assess unit-level eligibility, transaction costs and long-term objectives with appropriate professional support. The key consideration for Forest City property buyers in 2026 is that the legal and tax framework for eligible transactions is now sufficiently defined to allow detailed verification before an SPA is signed.
Hashtag: #ForestCity
The issuer is solely responsible for the content of this announcement.
About Forest City Special Financial Zone
Located in Iskandar Puteri, Johor, Forest City Special Financial Zone (FCSFZ) is Malaysia’s first designated special financial zone and a key financial-services component of the Johor–Singapore Special Economic Zone. It is positioned to attract financial institutions, multinational corporations, high-net-worth individuals and businesses operating in wealth management, financial technology and global business services.
Its incentive framework includes a 0% income tax rate for qualifying Single Family Office Vehicles for up to 20 years, a preferential 5% corporate tax rate for approved qualifying activities, and a special 15% personal income tax rate for eligible knowledge workers, subject to the applicable conditions, regulatory approvals and prevailing legislation. Forest City also holds duty-free island status, further strengthening its appeal as a regional investment, business and wealth-management destination near Singapore.
WILLEMSTAD, CURAÇAO – Media OutReach Newswire – 31 July 2026 – The second edition of 1win Essence, the international online Dota 2 tournament series organized by 1win, is now underway, bringing together 10 internationally recognized teams from Europe, Asia, North America, and South America.
Running through August 5, the tournament reflects 1win’s commitment to supporting the global eSports movement by creating opportunities for top organizations to compete and engage with fans worldwide.
Building on the inaugural edition, 1win Essence II features a refined competitive format designed to deliver a more streamlined experience for participating teams and viewers. This year’s lineup includes BetBoom Team, Team Liquid, Team Falcons, 1win Team, Nigma Galaxy, MOUZ, GamerLegion, LGD Gaming, Vici Gaming, and OG.
The tournament opened with a round-robin group stage, where teams were divided into two groups of five competing in best-of-two series. The competition will continue with double-elimination playoffs before concluding with the Grand Final on August 5.
As matches continue throughout the week, 1win Essence II highlights 1win’s broader commitment to supporting competitive gaming and fostering opportunities for players, organizations, creators, and esports communities around the world.
The issuer is solely responsible for the content of this announcement.
About 1win Essence
1win Essence is a global online Dota 2 tournament. Organized by 1win, the competition combines elite-level gameplay, substantial prize pools, and professional broadcasts, offering fans high-quality Dota 2 action throughout the season.
HKSTP Hosts Showcase Featuring Clinical Progress from 10 Park Companies and Real-Life Patient Stories
HONG KONG SAR – Media OutReach Newswire – 31 July 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) today hosted the HKSTP Cell and Gene Therapy (CGT) Showcase 2026 at the Charles K. Kao Auditorium, Hong Kong Science Park, with support from Invest Hong Kong. The event brought together more than 200 representatives from the healthcare, academic, investment and regulatory sectors, both locally and from overseas. A major milestone announced at the event was that HKSTP partner company Hong Kong Regen Medtech Limited (HKRM) has become the first facility in Hong Kong to be recognised by the Pharmacy and Poisons Board of Hong Kong (PPBHK) as an allogeneic mesenchymal stem cell (MSC) PIC/S GMP manufacturing facility, enabling the production of advanced therapy products for clinical trials.
HKSTP hosted the HKSTP CGT Showcase 2026, bringing together local and overseas I&T enterprises, medical experts, researchers, investors and patient representatives to explore the clinical translation and broader development of cell and gene therapy.
Mr Terry Wong, CEO of HKSTP, said in his remarks: “Cell and gene therapy is one of the fastest-growing fields in life and health tech. The establishment of Hong Kong’s first stem cell production facility certified to PIC/S GMP standards at Hong Kong Science Park marks a significant milestone for the city’s life and health tech ecosystem. The significance of this certification goes far beyond technology alone. It signifies not only that production has met the highest international safety standards, but also that patients and their families can choose locally manufactured cell therapy products with confidence and complete trust. This is a tangible achievement that will enable every Hong Kong citizen to benefit directly. As the orchestrator of Hong Kong’s innovation and technology (I&T) ecosystem, HKSTP has been proactively connecting the life and health tech community with partners, investors and academia. Through a diverse range of incubation programmes, we provide our park companies with seed funding, innovation space, world-class infrastructure and regulatory support, helping them overcome challenges in the journey from laboratory research to clinical translation and turning scientific breakthroughs into real therapeutic outcomes for patients. We will continue to drive ecosystem development and fully support local I&T enterprises in bringing research achievements ‘Made in Hong Kong’ to the global stage.”
Hong Kong’s First PIC/S GMP Stem Cell Production Facility Bridges a Critical Gap from Research to Clinical Application
One of the highlights of the event was HKRM, an HKSTP partner company, recently obtaining Hong Kong’s first PIC/S GMP licence for stem cell production and operating the related manufacturing facility at Hong Kong Science Park, marking a key step in advancing the clinical translation of advanced therapies in Hong Kong. PIC/S GMP is internationally recognised as the gold standard for pharmaceutical manufacturing quality. Facilities must undergo rigorous international assessment to ensure that every batch is produced in a strictly controlled environment.
Mr Stanley Sy, HKRM Co-founder and CEO, said: “HKRM’s attainment of Hong Kong’s first PIC/S GMP certification for stem cell production marks not only an important milestone in the company’s development, but also signifies that Hong Kong now has the critical infrastructure needed to further support the clinical translation of advanced cell therapies. A stringent, internationally recognised manufacturing quality system helps ensure product consistency and traceability, while strengthening the confidence of medical and regulatory authorities in locally manufactured cell-based products. Based at Hong Kong Science Park, HKRM is grateful for the longstanding support of HKSTP. We also look forward to working with research and clinical partners in the Park to bring more promising therapeutic solutions from Hong Kong to the international stage.”
Patients, Families and Doctors Share First-hand Stories of the Journey from Cell Banking to Clinical Breakthroughs
The event also featured first-hand experiences from patients, their families and doctors on their treatment journeys. Park company Mononuclear Therapeutics (MonoTx) operates Hong Kong’s first AABB-accredited public cord blood bank and haematopoietic stem cell apheresis facility at Hong Kong Science Park, with more than 2,000 cord blood units in storage.
Dr Wendy Cheng, Chief Operating Officer of MonoTx, joined Professor Leung Tak Yeung and Professor Ronald Wang of the Department of Obstetrics and Gynaecology at The Chinese University of Hong Kong (CUHK) to share research findings and patient cases with patient families.
Professor Leung Tak Yeung’s team at CUHK is studying a treatment for foetuses with severe alpha-thalassaemia by processing the mother’s stem cells through MonoTx and infusing them into the foetus, to investigate whether the foetus can develop immune tolerance to the mother’s stem cells and thereby improve clinical outcomes.
Professor Ronald Wang’s team is using cord blood to treat neonatal brain injury. Preliminary findings suggest that cord blood infusion within 48 hours of birth may help repair brain injury and improve the child’s developmental outcomes later in life.
360 Life Sciences Companies Gather at Hong Kong Science Park, Reinforcing Hong Kong’s Position as an International Health and Medical Innovation Hub
Hong Kong Science Park is home to more than 360 life sciences companies, while the number of cell and gene therapy (CGT) enterprises continues to grow, spanning frontier fields such as stem cells, gene editing, personalised cancer vaccines and CAR-T immunotherapy, and addressing diseases including cancer, heart failure and neurodegenerative disorders. HKSTP will continue to strengthen Hong Kong’s position as an international health and medical innovation hub by accelerating the translation and application of more locally developed R&D outcomes for the benefit of patients, the industry and society. In doing so, it aims to make innovative therapies more accessible and enable Hong Kong to play an even greater role on the global life and health tech stage.
Hashtag: #HKSTP
The issuer is solely responsible for the content of this announcement.
Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 14 unicorns, more than 17,000 research professionals and over 2,400 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.
Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.
Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong.
More information about HKSTP is available at www.hkstp.org.
New regional programme will assess environmental hygiene practices, support hospital improvement, and recognise excellence in patient safety across Asia Pacific, with winners honoured at the APSIC 2028 Congress.
SINGAPORE – Media OutReach Newswire – 31 July 2026 – The Asia Pacific Society of Infection Control (APSIC), in collaboration with Schuelke, has launched the APSIC Environment Hygiene Excellence Award, a programme to recognise hospitals that demonstrate excellence in environmental hygiene and infection prevention across the Asia Pacific region. The programme was announced today at the APSIC 2026 Congress.
APSIC Executive Committee (ExCo) members and APSIC Environment Hygiene Excellence Award (APSIC EHEA) Expert Panel representatives at APSIC 2026 Malaysia. Pictured from left are Prof. Doo Ryeon Chung, Dr. Zhiyong Zong, Prof. Surinder Pada, Ms. Lily Lang Ren Lee, Dr. Namita Jaggi, Prof. Wing Hong Seto, Prof. Moi Lin Ling, Ms. Glenys Harrington and Ms. Patricia Tai-Yin Ching. The APSIC EHEA Expert Panel comprises Prof. Moi Lin Ling (Programme Chair), Prof. Anucha Apisarnthanarak (APSIC President, not pictured), Ms. Patricia Tai-Yin Ching (APSIC Vice President), Prof. Surinder Pada, Dr. Namita Jaggi and Prof. Sasheela Sri La Ponnampalavanar (not pictured).
Environmental hygiene is a critical component of infection prevention and patient safety, yet standards and implementation of environmental hygiene vary significantly across the region’s healthcare settings. The new programme aims to raise awareness, strengthen best practices, and support hospitals to improve environmental hygiene through a structured, scientifically guided framework.
Participating hospitals will be evaluated using APSIC-developed guidelines and audit criteria, with assessments conducted through an independent scientific framework led by an APSIC-appointed expert panel comprising infection prevention specialists from across the region.
“Environmental hygiene is fundamental to infection prevention and patient safety, yet often under-recognised. This initiative brings renewed focus to raising standards across healthcare systems in Asia Pacific,” said Professor Moi Lin Ling, APSIC Programme Chair, APSIC Environment Hygiene Excellence Award
Through this regional collaboration, APSIC and Schuelke aim to:
Promote awareness and adoption of best practices in environmental hygiene across healthcare institutions in Asia Pacific.
Provide hospitals with structured tools to assess performance and identify opportunities for improvement.
Enable benchmarking and knowledge exchange among healthcare institutions to advance infection prevention standards regionally.
Shortlisted hospitals will receive expert-led educational support, including regional webinars and on-site training sessions, to help strengthen infection prevention strategies and improve operational environmental hygiene practices. Finalists will undergo an on-site audit by APSIC experts, and winners will be honoured at the APSIC 2028 Congress.
“As a long-standing partner in infection prevention, Schuelke is committed to supporting healthcare institutions in advancing environmental hygiene standards through scientific collaboration and education,” said Patrick Kaminski, President and CEO, Schuelke Asia Pacific.
The programme represents one of the first coordinated regional efforts to standardise, assess, and recognise excellence in environmental hygiene across healthcare systems in Asia Pacific. By combining scientific criteria, expert review, and practical education, the initiative is designed to support meaningful and measurable improvements in hospital hygiene, patient safety, and infection prevention outcomes.
Healthcare institutions interested in participating in the programme can find more information at www.ehea.health Hashtag: #Schuelke
The issuer is solely responsible for the content of this announcement.
About Asia Pacific Society of Infection Control (APSIC)
APSIC was established in 1998 and is a multinational, voluntary organisation dedicated to advancing infection prevention and control practices to reduce hospital-associated infections, respond to emerging and re-emerging infectious diseases, and improve patient outcomes. APSIC brings together multidisciplinary infection prevention and control professionals across the region to share knowledge, experience, quality improvement initiatives, and research findings through training courses, seminars, congresses, and conferences in Asia Pacific. APSIC also works to establish collaborative partnerships that promote cost-effective, evidence-based practices across the region.
Schuelke, headquartered in Norderstedt, Germany, is a global leader in infection prevention and control with more than 135 years of experience. Guided by its purpose, “We protect lives worldwide,” Schuelke is committed to advancing health and safety through innovative solutions, scientific expertise, and strong partnerships across the healthcare ecosystem.
In an increasingly interconnected world where infectious risks transcend borders, Schuelke works closely with healthcare professionals, institutions, and industry partners to strengthen infection prevention practices across diverse care settings.
The company operates across four key business areas—Healthcare, Consumer Health (OTC), Direct Patient Care, and Life Sciences—offering a comprehensive portfolio of solutions spanning antisepsis, disinfection, hygiene management, and specialised applications.
With globally recognised brands such as mikrozid®, microshield®, octenisept®, desmanol®, and desderman®, Schuelke provides trusted solutions for surface disinfection, skin antisepsis, hand hygiene, and wound care, supporting healthcare professionals in maintaining safe and effective clinical environments.
HONG KONG SAR- Media OutReach Newswire – 31 July 2026 – AECOM, the trusted global infrastructure leader, officially launched its new Hong Kong office and Asia headquarters at 83 King Lam Street in Cheung Sha Wan, unveiling a workplace that reflects how the company is evolving to meet the needs of its employees, clients and communities. The ceremony was attended by Jill Hudkins, global chief executive, AECOM Advisory, alongside clients, partners and employees.
Designed as a living demonstration of the way AECOM works, the office brings together people, technology and sustainable design in a future-ready environment that reflects both the company’s values and its deep connection to Hong Kong.
The new workplace underlines the company’s commitment to Hong Kong. At a time of transformational development in Hong Kong, including landmark initiatives such as the Northern Metropolis and SKYTOPIA, it strengthens AECOM’s ability to support clients locally while leveraging its breadth of expertise across Asia.
Ian Chung, chief executive of AECOM’s Asia region, said: “Our new Hong Kong office and Asia headquarters represents AECOM’s largest office investment in Asia and reflects our confidence in Hong Kong’s future. For more than 50 years, we have partnered with clients and communities to help shape the city’s development. This new workplace will strengthen collaboration and innovation across our teams, enabling us to support the opportunities ahead and continue growing future Hong Kong together with our clients and partners.”
Johnny Cheuk, executive leader, Hong Kong, AECOM, said: “As Hong Kong enters a new era of development, creating the right environment for our people and clients to collaborate has never been more important. Our new office is designed to foster innovation, collaboration and multidisciplinary teamwork, strengthening our ability to deliver better outcomes for clients and communities. This future-ready workplace will help us bring together the talent and expertise needed to shape Hong Kong’s next chapter of growth.”
Occupying approximately 126,000 gross square feet across four floors, the workplace is designed around AECOM’s Freedom to Grow framework, supporting flexible, performance-led ways of working through a variety of spaces for focused work, project delivery, hybrid meetings and collaboration. Client engagement areas, innovation spaces and technology-enabled environments further support co-creation and knowledge sharing. It demonstrates the same people-centered and future-ready principles that AECOM helps clients deliver every day.
A digital dashboard powered by IoT sensors provides real-time insights into energy consumption and indoor air quality, making workplace sustainability performance visible and measurable. The relocation also embraced circular economy principles. More than 900 furniture items from AECOM’s previous Sha Tin office were donated to local schools and non-governmental organizations, extending their useful life while reducing landfill waste.
Employee wellbeing was integral to the design. Activity-based workspace design promotes the exchange of ideas, collaboration, socialization and focused work, while natural materials, green walls and planted dividers bring biophilic elements into the workplace. Bamboo finishes and sustainable carpets help reduce the environmental impact of the fit-out.
The workplace also reflects AECOM’s multidisciplinary strength in infrastructure delivery. The office is located at 83 King Lam Street, a twin-tower commercial development for which AECOM provided structural, geotechnical and façade engineering services. The project was recognized at the HKIE Structural Division Structural Excellence Award 2025.
Download more high-resolution images here. Hashtag: #AECOMHongKong #AECOMHKNewOffice #GrowingFutureHKTogether #DeliveringABetterWorld
The issuer is solely responsible for the content of this announcement.
About AECOM
AECOM is the global infrastructure leader, committed to delivering a better world. As a trusted professional services firm powered by deep technical abilities, we solve our clients’ complex challenges in water, environment, energy, transportation and buildings. Our teams partner with public- and private-sector clients to create innovative, sustainable and resilient solutions throughout the project lifecycle — from advisory, planning, design and engineering to program and construction management. AECOM is a Fortune 500 firm that had revenue of US$16.1 billion in fiscal year 2025. Learn more at aecom.com.
新辦事處總樓面面積約126,000平方呎，橫跨四個樓層，並以AECOM的「Freedom to Grow」工作模式框架為設計藍本，透過多元化工作空間支援靈活高效的工作模式，滿足深度工作、項目交付、混合模式會議及團隊協作等不同需求。辦公室亦設有客戶交流區、創新空間及科技驅動的工作環境，以促進共同創造及知識共享，體現AECOM一直協助客戶實踐的以人為本及面向未來的發展理念。
新辦事處所在的83瓊林街亦體現AECOM在大型基建及建築項目交付方面的跨專業實力。AECOM為這項雙子塔商業發展項目提供結構、岩土及幕牆工程服務。該項目於香港工程師學會結構分部舉辦的「2025年度卓越結構大獎」（Structural Excellence Award 2025）中獲得嘉許，充分肯定項目團隊在工程設計、技術創新及項目交付方面的卓越表現。
HONG KONG SAR – Media OutReach Newswire – 31 July 2026 – XTransfer, the world’s leading B2B cross-border trade payment platform, is proud to announce it has been named, for the first time, to CNBC’s 2026 list of the World’s Top Fintech Companies (Payments Segment). The inclusion not only recognises XTransfer‘s ongoing commitment to empowering SMEs with secure, efficient and accessible cross-border payment solutions, but also highlights its growing influence in the industry.
XTransfer Named to CNBC’s World’s Top Fintech Companies 2026
The annual ranking, produced in collaboration with Statista, the world-leading statistics portal and industry ranking provider, recognises the most innovative and high-impact fintech firms globally.
“This recognition reflects the dedication of our team and the trust our customers and partners place in us every day,” said Bill Deng, Founder and CEO of XTransfer. “Cross-border financial operations can be complex, especially for SMEs. We focus on solving the real operational challenges behind international payments, reducing friction, improving visibility, and strengthening risk controls, so businesses can concentrate on growth.”
XTransfer‘s inclusion underscores the company’s growing role in the global payments ecosystem and its long-term mission to make cross-border trade payments simpler, safer, and more accessible for SMEs worldwide. XTransfer will continue to invest in compliance and product innovation, while deepening collaboration with top-tier financial institutions to help more businesses trade globally with confidence.
CNBC’s World’s Top Fintech Companies list evaluates thousands of firms across seven key segments, including Payments, Digital Assets, and Enterprise Technology. Companies were assessed based on quantitative KPIs, growth metrics, and industry influence, with data sourced from public reports, company submissions, and independent research.
Based on the results of the study, XTransfer is honoured to be recognised on CNBC’s World’s Top Fintech Companies 2026 list. View list here.
The issuer is solely responsible for the content of this announcement.
XTransfer
XTransfer, the world’s largest B2B cross-border trade payment platform with over US$60 billion TPV in 2025, according to CIC. Founded in 2017 as one of the first payment platforms worldwide dedicated to B2B cross-border trade, we serve the largest customer base of over 890,000 registered SMEs globally.
We connect top-tier financial institutions directly to SMEs, the backbone of global trade, giving businesses of every size access to the same secure, compliant and seamless payment infrastructure once reserved for multinationals. As of March 31, 2026, we provide payment services across more than 200 countries and regions through partnerships with financial institutions, including some of the most established international banks around the world.
www.hkstp.org
https://apsic-apac.org/
aecom.com
https://www.xtransfer.com
https://www.linkedin.com/company/xtransfer.cn
https://x.com/xtransferglobal
https://www.linkedin.com/company/xtransfer.cn
https://x.com/xtransferglobal